Please try another search
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company’s principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides skin care products. In addition, the company provides CDMO/CMO services. The company was founded in 2003 and is headquartered in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Shuqing Xie | 55 | 2021 | Non-Independent Director |
Xiaoqing Teng | 58 | 2021 | Chairman of the Supervisory Board |
Yuan Bi | 35 | 2021 | Board Secretary, VP & Director |
Xiong Wen Hu | 58 | 2014 | Member of the Supervisory Board |
Xiang Wu Ye | 72 | 2014 | Chairman of the Board, GM & CFO |
Shendong Zhou | 33 | 2023 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review